In the journal Cancer Cell, Eunhee Kim et al. demonstrated that in glioblastoma (GBM), EZH2 binds to and methylates STAT3, which enhances STAT3 activity by increasing tyrosine phosphorylation of STAT3 [25]. The gene discussed is EZH2; the disease is cancer.